Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
At close: Nov 9, 2026
Syros Pharmaceuticals Market Cap
Syros Pharmaceuticals has a market cap or net worth of $10.73 thousand as of November 10, 2026. It is the 51,856th most valuable company in the world and the 7,792nd biggest in the United States. Its market cap has decreased by 20.00% in one year.
Market Cap
10.73K
Enterprise Value
n/a
Revenue
386.00K
Global Rank
Country Rank
#7,792 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from 413.10M to 10.73K, a decrease of -100.00%. That is a compound annual growth rate of -63.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 10.73K | 14.29% |
| Dec 31, 2025 | 9.39K | -99.85% |
| Dec 31, 2024 | 6.17M | -96.96% |
| Dec 29, 2023 | 202.59M | 179.01% |
| Dec 30, 2022 | 72.61M | -64.04% |
| Dec 31, 2021 | 201.95M | -59.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scopus BioPharma | 16.83K |
| Bio-Path Holdings | 16.17K |
| Statera Biopharma | 14.52K |
| Scorpius Holdings | 12.23K |
| ObsEva | 11.72K |
| Trevena | 10.64K |
| GeneLink | 10.60K |
| Carisma Therapeutics | 8.37K |